Advertisement for orthosearch.org.uk
Results 1 - 2 of 2
Results per page:
Applied filters
Content I can access

Include Proceedings
Dates
Year From

Year To
Orthopaedic Proceedings
Vol. 101-B, Issue SUPP_5 | Pages 135 - 135
1 Apr 2019
Post C Schroder FF Simonis FJJ Peters A Huis In't Veld R Verdonschot N
Full Access

Introduction

Fifteen percent of the primary total knee arthroplasties (TKA) fails within 20 years. Among the main causes for revision surgery are instability and patellofemoral pain. Currently, the diagnostic pathway requires various diagnostic techniques to reveal the original cause for the failed knee prosthesis and is therefore time consuming and inefficient.

Accordingly, there is a growing demand for a diagnostic tool that is able to simultaneously visualize soft tissue structures, bone and TKA. Magnetic resonance imaging (MRI) is capable of visualising all the structures in the knee although a trade- off needs to be made between metal artefact reducing capacities and image quality. Low-field MRI (0.25T) results in less metal artefacts and a lower image quality compared with high-field MRI (1.5T). The aim of this study is to develop a MRI imaging guide to image the problematic TKA and to evaluate this guide by comparing low-field and high-field MRI on a case study.

Method

Based on literature and current differential diagnostic pathways a guide to diagnose patellofemoral pain, instability, malposition and signs of infection or fracture with MRI was developed. Therefore, methods as Insall Salvati, patellar tilt angle and visibility of fluid and soft tissues were chosen. Visibility was scored on a VAS scale from 0 to 100mm (0mm zero visibility, 100mm excellent visibility).

Subsequently, this guide is used to analyse MRI scans made of a volunteer (female, 61 years, right knee) with primary TKA (Biomet, Zimmer) in sagittal, coronal and transversal direction with a FSE PD metal artefact reducing (MAR) sequence (TE/TR 12/1030ms, slice thickness 4.0mm, FOV 260×260×120mm3, matrix size 224×216) on low-field MRI (Esaote G-scan Brio, 0.25T) and with a FSE T1-weighted high bandwidth MAR sequence (TE/TR 6/500ms, slice thickness 3.0mm, FOV 195×195×100mm3, matrix size 320×224) on high-field MRI (Avanto 1.5T, Siemens).

Scans were analysed three times by one observer and the intra observer reliability was calculated with a two-way random effects model intra class correlation coefficient (ICC).


Orthopaedic Proceedings
Vol. 92-B, Issue SUPP_I | Pages 78 - 78
1 Mar 2010
Peters A Schell H Lienau J Toben D Bail H Duda G Kaspar K
Full Access

The aim of this study was to examine the therapeutic potential of locally transplanted MSCs or osteoprogenitor cells (OPCs) in delayed unions. Autologous MSCs were cultured in DMEM or osteogenic medium. A femoral osteotomy was created in rats and stabilized with an external fixator. Except for the Control-group (C-group), a delayed union was induced by cauterization of the periosteum and bone marrow removal. After 2 days, these animals received an injection of DMEM in the gap containing MSCs (MSC-group), OPCs (OPC-group) or no cells (Sham-group). Histomorphometrical analysis showed significant differences in the fraction of mineralized bone, cartilage and connective tissue between the C- and the Sham-group after 2 (p=0.001) and 8 weeks (p≤0.009). After 2 weeks, the MSC- and OPC-groups developed a larger cartilage fraction (each p=0.019) compared to the Sham-group. Biomechanical testing after 8 weeks demonstrated a significantly lower torsional stiffness (p=0.001) in the Sham-group compared to the C-group. Both the MSC and OPC groups showed a higher torsional stiffness than the Sham-group with statistically significant differences (p< 0.002) in the OPC-group. Locally applied MSCs and OPCs slightly improved the healing in this model. The MSCs were less effective compared to the OPCs. The less than expected healing improvement of both cell treatments may be related to an unfavourable microenvironment at the application time. An explanation for the superior outcome of the OPCs might be that the OPCs may be protected by macroscopically visible matrix at the transplantation time point.